User profiles for Alexander Farahani
Alexander A. FarahaniMassachusetts General Hospital Verified email at mgh.harvard.edu Cited by 484 |
Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis
M Farahani, H Mulinder, A Farahani… - … journal of STD & …, 2017 - journals.sagepub.com
The advent of antiretroviral therapy has significantly improved AIDS-related morbidity and
mortality. Yet, among people living with HIV, deaths due to non-AIDS-defining illnesses have …
mortality. Yet, among people living with HIV, deaths due to non-AIDS-defining illnesses have …
Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases
…, ECE Wassenaar, WR Jeck, MS Taylor, AA Farahani… - Nature …, 2020 - nature.com
Genetic diversity among metastases is poorly understood but contains important information
about disease evolution at secondary sites. Here we investigate inter- and intra-lesion …
about disease evolution at secondary sites. Here we investigate inter- and intra-lesion …
[HTML][HTML] Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)
Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical
behavior, histologic characteristics, and molecular landscape are not well understood. We …
behavior, histologic characteristics, and molecular landscape are not well understood. We …
[HTML][HTML] Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
YH Chu, LJ Wirth, AA Farahani, V Nosé, WC Faquin… - Modern Pathology, 2020 - Elsevier
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …
[HTML][HTML] Diagnostic value of MAML2 rearrangements in mucoepidermoid carcinoma
JC Thierauf, AA Farahani, BI Indave, AZ Bard… - International journal of …, 2022 - mdpi.com
Mucoepidermoid carcinoma (MEC) is often seen in salivary glands and can harbor MAML2
translocations (MAML2+). The translocation status has diagnostic utility as an objective …
translocations (MAML2+). The translocation status has diagnostic utility as an objective …
[HTML][HTML] Identification of fusions with potential clinical significance in melanoma
Though uncommon in melanoma, gene fusions may have therapeutic implications. Next
generation sequencing-based clinical assays, designed to detect relevant gene fusions, …
generation sequencing-based clinical assays, designed to detect relevant gene fusions, …
Implementation and clinical adoption of precision oncology workflows across a healthcare network
…, LM Spring, N Jessop, AA Farahani… - The …, 2022 - academic.oup.com
Background Precision oncology relies on molecular diagnostics, and the value-proposition
of modern healthcare networks promises a higher standard of care across partner sites. We …
of modern healthcare networks promises a higher standard of care across partner sites. We …
Developmental deconvolution for classification of cancer origin
Here we map the developmental trajectories of tumors. We deconvolute tumor transcriptomes
into signals for mammalian developmental programs and use this information to construct …
into signals for mammalian developmental programs and use this information to construct …
Integrated radiology, pathology, and pharmacy program to accelerate access to osimertinib
…, NZ Georgantas, FJ Fintelmann, A Farahani… - JCO Oncology …, 2023 - ascopubs.org
PURPOSE Targeted therapy yields superior outcomes relative to genotype-agnostic therapy
for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. Workflows …
for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer. Workflows …
Prognostic biomarkers for survival in mucosal melanoma
…, S Jobbagy, R Purohit, AA Farahani… - Pigment Cell & …, 2023 - Wiley Online Library
Mucosal melanoma (MM) is a rare subtype of melanoma with an aggressive clinical course.
In cutaneous melanoma (CM), the absence of pigmentation and presence of NRAS/KRAS …
In cutaneous melanoma (CM), the absence of pigmentation and presence of NRAS/KRAS …